Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study.

ABSTRACT:

Background and purpose

To assess neurological manifestations and health-related quality of life (QoL) 3 months after COVID-19.

Methods

In this prospective, multicenter, observational cohort study we systematically evaluated neurological signs and diseases by detailed neurological examination and a predefined test battery assessing smelling disorders (16-item Sniffin Sticks test), cognitive deficits (Montreal Cognitive Assessment), QoL (36-item Short Form), and mental health (Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist-5) 3 months after disease onset.

Results

Of 135 consecutive COVID-19 patients, 31 (23%) required intensive care unit (ICU) care (severe), 72 (53%) were admitted to the regular ward (moderate), and 32 (24%) underwent out

SUBMITTER: Rass V 

PROVIDER: S-EPMC8250725 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature